APA

Ghesquières H., Cartron G., Seymour J. F., Delfau-Larue M., Offner F., Soubeyran P., Perrot A., Brice P., Bouabdallah R., Sonet A., Dupuis J., Casasnovas O., Catalano J. V., Delmer A., Jardin F., Verney A., Dartigues P. & Salles G. (20130110). Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. : Blood.

Chicago

Ghesquières Hervé, Cartron Guillaume, Seymour John Francis, Delfau-Larue Marie-Hélène, Offner Fritz, Soubeyran Pierre, Perrot Aurore, Brice Pauline, Bouabdallah Réda, Sonet Anne, Dupuis Jehan, Casasnovas Olivier, Catalano John Vincent, Delmer Alain, Jardin Fabrice, Verney Aurélie, Dartigues Peggy and Salles Gilles. 20130110. Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. : Blood.

Harvard

Ghesquières H., Cartron G., Seymour J. F., Delfau-Larue M., Offner F., Soubeyran P., Perrot A., Brice P., Bouabdallah R., Sonet A., Dupuis J., Casasnovas O., Catalano J. V., Delmer A., Jardin F., Verney A., Dartigues P. and Salles G. (20130110). Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. : Blood.

MLA

Ghesquières Hervé, Cartron Guillaume, Seymour John Francis, Delfau-Larue Marie-Hélène, Offner Fritz, Soubeyran Pierre, Perrot Aurore, Brice Pauline, Bouabdallah Réda, Sonet Anne, Dupuis Jehan, Casasnovas Olivier, Catalano John Vincent, Delmer Alain, Jardin Fabrice, Verney Aurélie, Dartigues Peggy and Salles Gilles. Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. : Blood. 20130110.